News for 'Drug Administration'

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Rediff.com9 Mar 2024

The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

Industry bodies seek safeguards against influx of Chinese goods

Industry bodies seek safeguards against influx of Chinese goods

Rediff.com26 Apr 2025

Various industry bodies have sought immediate government intervention through the imposition of anti-dumping duties, claiming India has seen a surge in imports of Chinese goods over the past two weeks.

Natco medicine gets 'Orphan Drug' status

Natco medicine gets 'Orphan Drug' status

Rediff.com29 Mar 2011

Natco Pharma's anti-cancer drug, NRC-AN-019, has received 'Orphan Drug' designation from the US Food and Drug Administration (USFDA) for three indications - glioma (brain tumour), pancreatic cancer and chronic myelogenous leukemia.

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

10 Medical Streams After Class 12

10 Medical Streams After Class 12

Rediff.com15 May 2025

While MBBS continues to be the most sought-after stream for medical aspirants, post pandemic, the demand for skilled nurses and physiotherapists are on the rise, notes Nayagam PP, career counsellor and founder of EduJob360.

Bengal orders probe by CID, health dept into expired IV fluid case

Bengal orders probe by CID, health dept into expired IV fluid case

Rediff.com13 Jan 2025

The West Bengal government has ordered a CID probe into the death of a woman and three others falling critically ill after childbirth in a state-run hospital allegedly following the administration of 'expired' intravenous fluid. A 13-member committee will also investigate the matter parallelly. The decisions were taken at a review meeting chaired by Chief Minister Mamata Banerjee. The CM also holds the health portfolio. "We have asked the CID to investigate the matter. They will look into all aspects and find out whether there were procedural lapses and whether SOPs (standard operating procedures) were properly followed or not," Chief Secretary Manoj Pant said. Pant said the CM held a review meeting with officials of the state health department and gave a clear direction that such negligence in administrative and procedural lapses will not be tolerated. "Strict action will be taken against those found guilty of any procedural lapses or in treatment," he said. Referring to the initial report on the incident submitted by the committee, Pant admitted that "clear violations" of norms were found in this matter. A woman died and four others were critical after the delivery of babies at the Medinipur Medical College and Hospital allegedly due to the administration of expired intravenous fluid, prompting the health department to constitute the panel to investigate the matter.

New rules for Indian generic drug makers

New rules for Indian generic drug makers

Rediff.com29 Oct 2012

Regulator says fee would enable it to quicken approval process.

Amritsar hooch toll rises to 21; 10 held, 2 cops suspended

Amritsar hooch toll rises to 21; 10 held, 2 cops suspended

Rediff.com14 May 2025

Police said they have made five arrests in the incident. Those arrested have been identified as Prabhjit Singh, the main accused, Kulbir Singh, Sahib Singh, Gurjant Singh and Ninder Kaur, they said.

Trump's tariffs: How will these sectors in India be impacted?

Trump's tariffs: How will these sectors in India be impacted?

Rediff.com2 Apr 2025

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product.

USFDA nods Ranbaxy drug

USFDA nods Ranbaxy drug

Rediff.com23 Sep 2004

Ranbaxy Laboratories Ltd said on Thursday that it has bagged the US Food and Drug Administration's approval for manufacturing and marketing Loratadine and Pseudoephedrine Sulfate Extended-release tablets.

FDA diktat on 'wonder' drugs

FDA diktat on 'wonder' drugs

Rediff.com20 Apr 2005

Alarmed by the growing number of advertisements on 'miracle' drugs being shown on television channels, Maharashtra Food and Drug Administration

Standards violation: FDA seizes Caraco drugs

Standards violation: FDA seizes Caraco drugs

Rediff.com26 Jun 2009

The US Food and Drug Administration has seized drug products manufactured by Caraco Pharmaceutical, at the company's Michigan facilities in Detroit, Farmington Hills, and Wixom, the US FDA said on Thursday. The FDA seeks to immediately stop Caraco from further distributing drugs until there is assurance that the firm complies with good manufacturing requirements, it added.

Why US doctors want Indian drugs to be banned

Why US doctors want Indian drugs to be banned

Rediff.com24 Mar 2014

In the final part of a three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about American doctors' contempt for drugs exported from India and the ineptitude of the US Food and Drug Administration to stop the menace.

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Ranbaxy bags cardio drug deal

Ranbaxy bags cardio drug deal

Rediff.com10 Dec 2004

India hopes for temporary tariff waiver as US official comes calling

India hopes for temporary tariff waiver as US official comes calling

Rediff.com24 Mar 2025

India and the United States will finalize the contours, schedule of negotiations, and terms of reference for a proposed bilateral trade agreement (BTA) during a three-day meeting beginning Tuesday. The agreement is expected to be finalized in two tranches, with the first phase focusing on goods trade. The US team, led by Assistant US Trade Representative for South and Central Asia Brendan Lynch, will be in India from March 25-29 to discuss the agreement. Both countries are aiming to conclude the first phase of the agreement by fall 2025.

BSF mobilises more troops towards Pakistan border

BSF mobilises more troops towards Pakistan border

Rediff.com24 Feb 2025

The Border Security Force has ordered mobilisation of additional manpower at posts along the India-Pakistan border in Punjab and Jammu as part of its measures to strengthen the anti-infiltration grid and check the intrusion of drones carrying ammunition or drugs, official sources said Monday.

Indian majors lead race for US drug ingredient market

Indian majors lead race for US drug ingredient market

Rediff.com30 Jan 2013

In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.

Watson sends patent challenge notice to Ranbaxy for acne drug

Watson sends patent challenge notice to Ranbaxy for acne drug

Rediff.com20 Sep 2013

The drug is licensed to Ranbaxy Laboratories from Cipher Pharmaceuticals Inc of Mississauga, Ontario. It is currently protected by two issued patents listed in the FDA's approved drug products list, which expire in September 2021, the company said in a statement.

China apologises to Nigeria over fake drugs

China apologises to Nigeria over fake drugs

Rediff.com21 Sep 2009

China has formally apologised to Nigeria for alleged export of fake drugs including some labelled as 'Made in India' by some Chinese firms to the country and assured to take punitive action against those involved in the scandal.

Wockhardt gets USFDA nod for cardiac drug

Wockhardt gets USFDA nod for cardiac drug

Rediff.com16 Aug 2012

Wockhardt said it is launching the product immediately in the US market.

Expired IV fluid kills woman after delivery at Bengal hospital

Expired IV fluid kills woman after delivery at Bengal hospital

Rediff.com12 Jan 2025

A woman died and four others were critical after the delivery of babies at a state-run hospital in West Bengal's Paschim Medinipur district allegedly due to the administration of expired intravenous fluid, prompting the health department to order an investigation, officials said on Saturday.

Wockhardt launches prostate drug in US market

Wockhardt launches prostate drug in US market

Rediff.com28 Apr 2010

Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the drug.

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Rediff.com30 Nov 2024

The Manipur government has accused Mizoram Chief Minister Lalduhoma of stoking hatred and division through "unwarranted comments" and called on him to display "better statesmanship" by being a "good neighbour". In a statement, the Manipur government alleged that Lalduhoma's comments were part of a "greater agenda" to carve out a Kuki-Chin Christian nation from contiguous areas of Myanmar, India, and Bangladesh. It also warned against any attempt to "push" illegal Kuki-Chin immigrants from Mizoram into Manipur for land grabbing and the creation of a "Greater Mizoram." The Mizoram government could not be reached immediately for comment.

US to charge fee on generic drug sale application

US to charge fee on generic drug sale application

Rediff.com21 Jun 2012

This move could cost $299 million a year for Indian pharma players.

Cipla HIV drug gets USFDA nod

Cipla HIV drug gets USFDA nod

Rediff.com26 Jun 2006

Cipla has got tentative approval from the USFDA for its abbreviated new drug application for anti-HIV/AIDS drug Slamivudine.

Maharashtra drug body cracks down on misleading ads

Maharashtra drug body cracks down on misleading ads

Rediff.com7 May 2012

The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.

Now, Ranbaxy AIDS drug under US lens

Now, Ranbaxy AIDS drug under US lens

Rediff.com22 Sep 2008

It is now probing the quality of AIDS medicines supplied by the company to developing countries under US government-funded programmes. Estimates suggest that Ranbaxy has received over $9 million from the programme so far. Ranbaxy had a turnover of $1.5 billion in 2007-08, of which a quarter came from US sales.

India gets ready to face possible fallout of US tariffs

India gets ready to face possible fallout of US tariffs

Rediff.com1 Apr 2025

The commerce ministry is working on different scenarios to assess the possible fallout of reciprocal tariffs to be imposed by the US administration on April 2 on its key trading partners including India, sources said. US President Donald Trump has said that April 2 will be 'Liberation Day' as he plans to announce tariffs or import duties to bring down America's trade deficit, and promote the country's manufacturing.

US drug regulator to inspect Aurobindo facilities

US drug regulator to inspect Aurobindo facilities

Rediff.com16 Aug 2012

Import alert on unit-6 facility might be lifted by FDA by Sept.

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Rediff.com17 Nov 2020

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.

No more Gobi Manchurian at north Goa's roadside food stalls

No more Gobi Manchurian at north Goa's roadside food stalls

Rediff.com6 Feb 2024

A civic body in North Goa has banned the sale of the popular street food 'Gobi Manchurian' at roadside stalls in its jurisdiction after concerns were raised about the unhygienic conditions in which the dish was prepared, an official said on Tuesday.

Soaring cancer drug costs may cripple medicare

Soaring cancer drug costs may cripple medicare

Rediff.com29 Jan 2009

A new report says laws crimp Medicare's ability to control costs on cancer, leading to a 267% increase in drug spending over seven years

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

Ranbaxy forged data, says US drug regulator

Ranbaxy forged data, says US drug regulator

Rediff.com26 Feb 2009

India's largest drug manufacturer, Ranbaxy Laboratories, had falsified data and test results of medicines manufactured at its Himachal Pradesh facility to obtain marketing approval in the United States, says the US Food and Drug Administration.

Ranbaxy gets USFDA nod for high BP drug

Ranbaxy gets USFDA nod for high BP drug

Rediff.com5 Mar 2009

Drug-maker Ranbaxy Laboratories on Thursday said it has received the US health regulator's approval to market Quinapril Hydrochloride and Hydrochlorothiazide tablets, used in treatment of high blood pressure, in different strengths in America.

US approves first HIV-prevention drug amid protests

US approves first HIV-prevention drug amid protests

Rediff.com17 Jul 2012

For the first time, a once-a-day pill which reduces the chance of contracting HIV among high risk groups "significantly" has got green signal in the United States, where 1.2 million people are infected by the deadly disease.

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.